Hashimoto, Kenji <br/><br/>
Pneumocystis jiroveci pneumonia in relation to CD4+ lymphocyte count in patients with B-cell non-Hodgkin lymphoma treated with chemotherapy.  [electronic resource] 

 -  Leukemia & lymphoma  Oct 2010 
 - 1816-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.3109/10428194.2010.506569  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Analysis of Variance<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>CD4 Lymphocyte Count<br/>CD4-CD8 Ratio<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Lymphoma, B-Cell--complications<br/>Male<br/>Middle Aged<br/>Pneumocystis carinii--drug effects<br/>Pneumonia, Pneumocystis--complications<br/>Risk Assessment<br/>Risk Factors<br/>Rituximab<br/>Treatment Outcome<br/>Trimethoprim, Sulfamethoxazole Drug Combination--therapeutic use<br/>Young Adult